0 (0%) | 09-27 09:28 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 12.81 | 1-year : | 14.96 |
Resists | First : | 10.97 | Second : | 12.81 |
Pivot price | 10.73 ![]() |
|||
Supports | First : | 10.37 | Second : | 10 |
MAs | MA(5) : | 10.84 ![]() |
MA(20) : | 10.58 ![]() |
MA(100) : | 10.33 ![]() |
MA(250) : | 10.6 ![]() |
|
MACD | MACD : | 0.1 ![]() |
Signal : | 0.1 ![]() |
%K %D | K(14,3) : | 79.6 ![]() |
D(3) : | 84.1 ![]() |
RSI | RSI(14): 69.5 ![]() |
|||
52-week | High : | 11.65 | Low : | 9.48 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ VTN ] has closed below upper band by 38.0%. Bollinger Bands are 33.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 10.91 - 10.96 | 10.96 - 11.01 |
Low: | 10.68 - 10.74 | 10.74 - 10.8 |
Close: | 10.72 - 10.81 | 10.81 - 10.9 |
Mon, 11 Aug 2025
Commercial vehicle testing centre in Wicklow to close after 35 years in business - The Irish Independent
Mon, 12 May 2025
Reversing VTN deficiency inhibits the progression of pancreatic cancer and enhances sensitivity to anti-PD1 immunotherapy - Frontiers
Wed, 07 May 2025
Visit of Mother Chiara Cazzuola to the VTN Province - Istituto Figlie di Maria Ausiliatrice
Wed, 05 Mar 2025
Vitronectin regulates lung tissue remodeling and emphysema in chronic obstructive pulmonary disease - ScienceDirect.com
Thu, 20 Feb 2025
VOTTUN - ICO Drops
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 15 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 11.6 (%) |
Shares Short | 46 (K) |
Shares Short P.Month | 112 (K) |
EPS | 0.28 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 11.67 |
Profit Margin | 39 % |
Operating Margin | 85.7 % |
Return on Assets (ttm) | 2.5 % |
Return on Equity (ttm) | 2.8 % |
Qtrly Rev. Growth | -10.2 % |
Gross Profit (p.s.) | 1.02 |
Sales Per Share | 1.02 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | -92.4 % |
Operating Cash Flow | 112 (M) |
Levered Free Cash Flow | 4 (M) |
PE Ratio | 37.27 |
PEG Ratio | 0 |
Price to Book value | 0.92 |
Price to Sales | 10.52 |
Price to Cash Flow | 1.4 |
Dividend | 0.07 |
Forward Dividend | 0 |
Dividend Yield | 0.6% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |